Index by author

November 01, 2001; Volume 28,Issue 11

A

  1. Aakre, O

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

  2. Ahern, M J

    1. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
      M D Smith, W Ross and M J Ahern
      The Journal of Rheumatology November 1 2001, 28 (11) 2504-2508;

  3. Algra, A

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  4. Allegri, A

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  5. Amano, H

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

  6. Aparicio, M J

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

B

  1. Baldi, F

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  2. Barr, S

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  3. Beaulieu, A

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  4. Bell, D A

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  5. Belmatoug, N

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  6. Bierma-Zeinstra, S

    1. Influence of work on the development of osteoarthritis of the hip: a systematic review.
      A Lievense, S Bierma-Zeinstra, A Verhagen, J Verhaar and B Koes
      The Journal of Rheumatology November 1 2001, 28 (11) 2520-2528;

  7. Bijlsma, J W

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  8. Bisogno, S

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  9. Bolognese, J

    1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
      L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
      The Journal of Rheumatology November 1 2001, 28 (11) 2494-2503;

  10. Brooks, P M

    1. Report of the Sixth Joint WHO/ILAR Task Force meeting on rheumatic diseases, January 16, 2000, Geneva, Switzerland.
      P M Brooks
      The Journal of Rheumatology November 1 2001, 28 (11) 2540-2543;

  11. Buchanan, W W

    1. Evidence based medicine: the median is not the message.
      W W Buchanan and W F Kean
      The Journal of Rheumatology November 1 2001, 28 (11) 2371-2372;

  12. Burns, T M

    1. Carpal tunnel sonography by the rheumatologist versus nerve conduction study by the neurologist.
      T M Burns
      The Journal of Rheumatology November 1 2001, 28 (11) 2560;

  13. Butterfield, J H

    1. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
      P S Kelkar, J H Butterfield and H G Teaford
      The Journal of Rheumatology November 1 2001, 28 (11) 2553-2554;

C

  1. Cacoub, P

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  2. Carbone, J

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  3. Chambers, E M

    1. Hyaluronic acid serum levels in fibromyalgia, nonspecific arm disorder, and controls.
      R D Wigley, B Page and E M Chambers
      The Journal of Rheumatology November 1 2001, 28 (11) 2563;

  4. Chemlal, K

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  5. Chieco-Bianchi, F

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  6. Choquette, D

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  7. Cidlowski, J

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  8. Cividino, A

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  9. Clarke, A E

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;
    2. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  10. Clauw, D J

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

  11. Cobo-Soriano, R

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  12. Cohen, P

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  13. Cortés, C

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  14. Cozzi, L

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  15. Cranney, A B

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

D

  1. Da Costa, D

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  2. Datson, N A

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  3. De Gennes, C

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  4. de Kloet, E R

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  5. Derijk, R H

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  6. Detera-Wadleigh, S D

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  7. Detora, L M

    1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
      L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
      The Journal of Rheumatology November 1 2001, 28 (11) 2494-2503;

  8. Dobkin, P L

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

E

  1. Edworthy, S

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  2. Ehrich, E W

    1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
      L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
      The Journal of Rheumatology November 1 2001, 28 (11) 2494-2503;

  3. Emery, P

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  4. Ensworth, S

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  5. Esdaile, J M

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

F

  1. Falsetti, P

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  2. Favero, E

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  3. Fawcett, P T

    1. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
      C D Rosé, P T Fawcett and K M Gibney
      The Journal of Rheumatology November 1 2001, 28 (11) 2555-2557;

  4. Feinn, R

    1. Factors associated with continued employment among patients with rheumatoid arthritis: a survival model.
      S Reisine, J Fifield, S J Walsh and R Feinn
      The Journal of Rheumatology November 1 2001, 28 (11) 2400-2408;

  5. Fernandes, J C

    1. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
      J P Pelletier, J C Fernandes, D V Jovanovic, P Reboul and J Martel-Pelletier
      The Journal of Rheumatology November 1 2001, 28 (11) 2509-2519;

  6. Fernández-Cruz, E

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  7. Ferro, F

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  8. Fifield, J

    1. Factors associated with continued employment among patients with rheumatoid arthritis: a survival model.
      S Reisine, J Fifield, S J Walsh and R Feinn
      The Journal of Rheumatology November 1 2001, 28 (11) 2400-2408;

  9. Fiocco, U

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  10. Fortin, P R

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  11. Frediani, B

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  12. Fujimoto, M

    1. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
      S Sato, K Komura, M Hasegawa, M Fujimoto and K Takehara
      The Journal of Rheumatology November 1 2001, 28 (11) 2460-2465;

G

  1. Galdo, F

    1. Epidemiological aspects of Behçet's disease in Galicia.
      J Graña, M O Sánchez-Meizoso and F Galdo
      The Journal of Rheumatology November 1 2001, 28 (11) 2565-2566;

  2. Gallego, M

    1. Juvenile rheumatoid arthritis-like polyarthritis in Nijmegen breakage syndrome.
      S D Rosenzweig, R A Russo, M Gallego and M Zelazko
      The Journal of Rheumatology November 1 2001, 28 (11) 2548-2550;

  3. Garcia-Estrada, J

    1. Prednisone induces anxiety and glial cerebral changes in rats.
      O Gonzalez-Perez, C Ramos-Remus, J Garcia-Estrada and S Luquin
      The Journal of Rheumatology November 1 2001, 28 (11) 2529-2534;

  4. Genant, H K

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  5. Ghaussy, N O

    1. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study.
      N O Ghaussy, W L Sibbitt Jr and C R Qualls
      The Journal of Rheumatology November 1 2001, 28 (11) 2449-2453;

  6. Gibney, K M

    1. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
      C D Rosé, P T Fawcett and K M Gibney
      The Journal of Rheumatology November 1 2001, 28 (11) 2555-2557;

  7. Gibson, T

    1. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
      P Gordon, J West, H Jones and T Gibson
      The Journal of Rheumatology November 1 2001, 28 (11) 2409-2415;

  8. Gladman, D

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  9. Gonzalez-Perez, O

    1. Prednisone induces anxiety and glial cerebral changes in rats.
      O Gonzalez-Perez, C Ramos-Remus, J Garcia-Estrada and S Luquin
      The Journal of Rheumatology November 1 2001, 28 (11) 2529-2534;

  10. Gordon, P

    1. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
      P Gordon, J West, H Jones and T Gibson
      The Journal of Rheumatology November 1 2001, 28 (11) 2409-2415;

  11. Gorevic, P D

    1. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
      M Naarendorp, U Kallemuchikkal, G J Nuovo and P D Gorevic
      The Journal of Rheumatology November 1 2001, 28 (11) 2466-2473;

  12. Gottschalk, R

    1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
      J P Kaltwasser, U Kessler, R Gottschalk, G Stucki and B Möller
      The Journal of Rheumatology November 1 2001, 28 (11) 2430-2436;

  13. Goulet, J R

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  14. Gracely, R H

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

  15. Gran, J T

    1. High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation.
      T Riise, B K Jacobsen and J T Gran
      The Journal of Rheumatology November 1 2001, 28 (11) 2425-2429;

  16. Graña, J

    1. Epidemiological aspects of Behçet's disease in Galicia.
      J Graña, M O Sánchez-Meizoso and F Galdo
      The Journal of Rheumatology November 1 2001, 28 (11) 2565-2566;

  17. Groner, K

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

H

  1. Häfner, R

    1. Evaluation of the ILAR criteria for juvenile idiopathic arthritis.
      M Krumrey-Langkammerer and R Häfner
      The Journal of Rheumatology November 1 2001, 28 (11) 2544-2547;

  2. Haga, M

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  3. Halberg, P

    1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
      S Jacobsen, S Ullman, G Q Shen, A Wiik and P Halberg
      The Journal of Rheumatology November 1 2001, 28 (11) 2454-2459;

  4. Harrison, B J

    1. Fish oils are beneficial to patients with established rheumatoid arthritis.
      R A Harrison and B J Harrison
      The Journal of Rheumatology November 1 2001, 28 (11) 2563-2565;

  5. Harrison, R A

    1. Fish oils are beneficial to patients with established rheumatoid arthritis.
      R A Harrison and B J Harrison
      The Journal of Rheumatology November 1 2001, 28 (11) 2563-2565;

  6. Harth, M

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  7. Hasegawa, M

    1. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
      S Sato, K Komura, M Hasegawa, M Fujimoto and K Takehara
      The Journal of Rheumatology November 1 2001, 28 (11) 2460-2465;

  8. Hashimoto, H

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

  9. Higuchi, T

    1. Images in rheumatology. Hemorrhagic schwannoma with purely cystic appearance in the shoulder.
      A Ogose, T Hotta, H Koda, H Umezu and T Higuchi
      The Journal of Rheumatology November 1 2001, 28 (11) 2558-2559;

  10. Hotta, T

    1. Images in rheumatology. Hemorrhagic schwannoma with purely cystic appearance in the shoulder.
      A Ogose, T Hotta, H Koda, H Umezu and T Higuchi
      The Journal of Rheumatology November 1 2001, 28 (11) 2558-2559;

  11. Huisman, A M

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

J

  1. Jacobs, J W

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  2. Jacobsen, B K

    1. High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation.
      T Riise, B K Jacobsen and J T Gran
      The Journal of Rheumatology November 1 2001, 28 (11) 2425-2429;

  3. Jacobsen, S

    1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
      S Jacobsen, S Ullman, G Q Shen, A Wiik and P Halberg
      The Journal of Rheumatology November 1 2001, 28 (11) 2454-2459;

  4. Ji, J D

    1. p53 codon 72 polymorphism and rheumatoid arthritis.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology November 1 2001, 28 (11) 2392-2394;

  5. Jones, H

    1. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
      P Gordon, J West, H Jones and T Gibson
      The Journal of Rheumatology November 1 2001, 28 (11) 2409-2415;

  6. Joseph, L

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  7. Jovanovic, D V

    1. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
      J P Pelletier, J C Fernandes, D V Jovanovic, P Reboul and J Martel-Pelletier
      The Journal of Rheumatology November 1 2001, 28 (11) 2509-2519;

K

  1. Kallemuchikkal, U

    1. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
      M Naarendorp, U Kallemuchikkal, G J Nuovo and P D Gorevic
      The Journal of Rheumatology November 1 2001, 28 (11) 2466-2473;

  2. Kaltwasser, J P

    1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
      J P Kaltwasser, U Kessler, R Gottschalk, G Stucki and B Möller
      The Journal of Rheumatology November 1 2001, 28 (11) 2430-2436;

  3. Kanigsberg, N D

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

  4. Kean, W F

    1. Evidence based medicine: the median is not the message.
      W W Buchanan and W F Kean
      The Journal of Rheumatology November 1 2001, 28 (11) 2371-2372;

  5. Kelkar, P S

    1. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
      P S Kelkar, J H Butterfield and H G Teaford
      The Journal of Rheumatology November 1 2001, 28 (11) 2553-2554;

  6. Kessler, U

    1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
      J P Kaltwasser, U Kessler, R Gottschalk, G Stucki and B Möller
      The Journal of Rheumatology November 1 2001, 28 (11) 2430-2436;

  7. Khalifa, P

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  8. Khine, A

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

  9. Kim, Y R

    1. p53 codon 72 polymorphism and rheumatoid arthritis.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology November 1 2001, 28 (11) 2392-2394;

  10. Koda, H

    1. Images in rheumatology. Hemorrhagic schwannoma with purely cystic appearance in the shoulder.
      A Ogose, T Hotta, H Koda, H Umezu and T Higuchi
      The Journal of Rheumatology November 1 2001, 28 (11) 2558-2559;

  11. Koes, B

    1. Influence of work on the development of osteoarthritis of the hip: a systematic review.
      A Lievense, S Bierma-Zeinstra, A Verhagen, J Verhaar and B Koes
      The Journal of Rheumatology November 1 2001, 28 (11) 2520-2528;

  12. Komura, K

    1. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
      S Sato, K Komura, M Hasegawa, M Fujimoto and K Takehara
      The Journal of Rheumatology November 1 2001, 28 (11) 2460-2465;

  13. Kraag, G R

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

  14. Krumrey-Langkammerer, M

    1. Evaluation of the ILAR criteria for juvenile idiopathic arthritis.
      M Krumrey-Langkammerer and R Häfner
      The Journal of Rheumatology November 1 2001, 28 (11) 2544-2547;

  15. Krupa, D

    1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
      L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
      The Journal of Rheumatology November 1 2001, 28 (11) 2494-2503;

L

  1. Lee, Y H

    1. p53 codon 72 polymorphism and rheumatoid arthritis.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology November 1 2001, 28 (11) 2392-2394;

  2. Leirisalo-Repo, M

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

  3. Lievense, A

    1. Influence of work on the development of osteoarthritis of the hip: a systematic review.
      A Lievense, S Bierma-Zeinstra, A Verhagen, J Verhaar and B Koes
      The Journal of Rheumatology November 1 2001, 28 (11) 2520-2528;

  4. Luquin, S

    1. Prednisone induces anxiety and glial cerebral changes in rats.
      O Gonzalez-Perez, C Ramos-Remus, J Garcia-Estrada and S Luquin
      The Journal of Rheumatology November 1 2001, 28 (11) 2529-2534;

M

  1. Marcolongo, R

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  2. Martel-Pelletier, J

    1. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
      J P Pelletier, J C Fernandes, D V Jovanovic, P Reboul and J Martel-Pelletier
      The Journal of Rheumatology November 1 2001, 28 (11) 2509-2519;

  3. McKendry, R J

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

  4. Molad, Y

    1. Sjögren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis.
      Y Molad, E Okon, P Stark and M Prokocimer
      The Journal of Rheumatology November 1 2001, 28 (11) 2551-2552;

  5. Möller, B

    1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
      J P Kaltwasser, U Kessler, R Gottschalk, G Stucki and B Möller
      The Journal of Rheumatology November 1 2001, 28 (11) 2430-2436;

  6. Morimoto, S

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

N

  1. Naarendorp, M

    1. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
      M Naarendorp, U Kallemuchikkal, G J Nuovo and P D Gorevic
      The Journal of Rheumatology November 1 2001, 28 (11) 2466-2473;

  2. Nardacchione, R

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  3. Närvänen, A

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

  4. Nikkari, S

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

  5. Nuovo, G J

    1. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
      M Naarendorp, U Kallemuchikkal, G J Nuovo and P D Gorevic
      The Journal of Rheumatology November 1 2001, 28 (11) 2466-2473;

O

  1. Ogose, A

    1. Images in rheumatology. Hemorrhagic schwannoma with purely cystic appearance in the shoulder.
      A Ogose, T Hotta, H Koda, H Umezu and T Higuchi
      The Journal of Rheumatology November 1 2001, 28 (11) 2558-2559;

  2. Okon, E

    1. Sjögren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis.
      Y Molad, E Okon, P Stark and M Prokocimer
      The Journal of Rheumatology November 1 2001, 28 (11) 2551-2552;

  3. Ooi, D S

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

P

  1. Page, B

    1. Hyaluronic acid serum levels in fibromyalgia, nonspecific arm disorder, and controls.
      R D Wigley, B Page and E M Chambers
      The Journal of Rheumatology November 1 2001, 28 (11) 2563;

  2. Parente, L

    1. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one?
      L Parente
      The Journal of Rheumatology November 1 2001, 28 (11) 2375-2382;

  3. Pelletier, J P

    1. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
      J P Pelletier, J C Fernandes, D V Jovanovic, P Reboul and J Martel-Pelletier
      The Journal of Rheumatology November 1 2001, 28 (11) 2509-2519;

  4. Penrod, J

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  5. Petzke, F

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

  6. Piette, J C

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  7. Prokocimer, M

    1. Sjögren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis.
      Y Molad, E Okon, P Stark and M Prokocimer
      The Journal of Rheumatology November 1 2001, 28 (11) 2551-2552;

  8. Puolakkainen, M

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

Q

  1. Qualls, C R

    1. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study.
      N O Ghaussy, W L Sibbitt Jr and C R Qualls
      The Journal of Rheumatology November 1 2001, 28 (11) 2449-2453;

R

  1. Ramos-Remus, C

    1. Prednisone induces anxiety and glial cerebral changes in rats.
      O Gonzalez-Perez, C Ramos-Remus, J Garcia-Estrada and S Luquin
      The Journal of Rheumatology November 1 2001, 28 (11) 2529-2534;

  2. Reboul, P

    1. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
      J P Pelletier, J C Fernandes, D V Jovanovic, P Reboul and J Martel-Pelletier
      The Journal of Rheumatology November 1 2001, 28 (11) 2509-2519;

  3. Reisine, S

    1. Factors associated with continued employment among patients with rheumatoid arthritis: a survival model.
      S Reisine, J Fifield, S J Walsh and R Feinn
      The Journal of Rheumatology November 1 2001, 28 (11) 2400-2408;

  4. Rich, E

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  5. Rigon, C

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  6. Riise, T

    1. High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation.
      T Riise, B K Jacobsen and J T Gran
      The Journal of Rheumatology November 1 2001, 28 (11) 2425-2429;

  7. Rodríguez-Mahou, M

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  8. Rodríguez-Molina, J J

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  9. Rosé, C D

    1. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
      C D Rosé, P T Fawcett and K M Gibney
      The Journal of Rheumatology November 1 2001, 28 (11) 2555-2557;

  10. Rosenzweig, S D

    1. Juvenile rheumatoid arthritis-like polyarthritis in Nijmegen breakage syndrome.
      S D Rosenzweig, R A Russo, M Gallego and M Zelazko
      The Journal of Rheumatology November 1 2001, 28 (11) 2548-2550;

  11. Ross, W

    1. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
      M D Smith, W Ross and M J Ahern
      The Journal of Rheumatology November 1 2001, 28 (11) 2504-2508;

  12. Rubaltelli, L

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  13. Ruiz-Tíscar, J L

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  14. Russo, R A

    1. Juvenile rheumatoid arthritis-like polyarthritis in Nijmegen breakage syndrome.
      S D Rosenzweig, R A Russo, M Gallego and M Zelazko
      The Journal of Rheumatology November 1 2001, 28 (11) 2548-2550;

S

  1. Sánchez-Meizoso, M O

    1. Epidemiological aspects of Behçet's disease in Galicia.
      J Graña, M O Sánchez-Meizoso and F Galdo
      The Journal of Rheumatology November 1 2001, 28 (11) 2565-2566;

  2. Sánchez-Ramón, S

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  3. Sarmiento, E

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  4. Sato, S

    1. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
      S Sato, K Komura, M Hasegawa, M Fujimoto and K Takehara
      The Journal of Rheumatology November 1 2001, 28 (11) 2460-2465;

  5. Schaaf, M J

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  6. Senécal, J L

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  7. Seoane, E

    1. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
      J Carbone, S Sánchez-Ramón, R Cobo-Soriano, E Seoane, M J Aparicio, J L Ruiz-Tíscar, M Rodríguez-Mahou, J J Rodríguez-Molina, E Sarmiento, C Cortés and E Fernández-Cruz
      The Journal of Rheumatology November 1 2001, 28 (11) 2437-2441;

  8. Seror, P

    1. Carpal tunnel sonography by the rheumatologist versus nerve conduction study by the neurologist.
      P Seror
      The Journal of Rheumatology November 1 2001, 28 (11) 2560-2561;

  9. Sfriso, P

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  10. Shen, G Q

    1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
      S Jacobsen, S Ullman, G Q Shen, A Wiik and P Halberg
      The Journal of Rheumatology November 1 2001, 28 (11) 2454-2459;

  11. Sibbitt, W L

    1. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study.
      N O Ghaussy, W L Sibbitt Jr and C R Qualls
      The Journal of Rheumatology November 1 2001, 28 (11) 2449-2453;

  12. Sibley, J T

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  13. Smith, C D

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

  14. Smith, D

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;

  15. Smith, M D

    1. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
      M D Smith, W Ross and M J Ahern
      The Journal of Rheumatology November 1 2001, 28 (11) 2504-2508;
    2. Abundant expression of common cytokine receptor chain (CD132) in rheumatoid joints.
      M D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2561-2563;

  16. Sohn, J

    1. p53 codon 72 polymorphism and rheumatoid arthritis.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology November 1 2001, 28 (11) 2392-2394;

  17. Song, G G

    1. p53 codon 72 polymorphism and rheumatoid arthritis.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology November 1 2001, 28 (11) 2392-2394;

  18. Sperling, R S

    1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
      L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
      The Journal of Rheumatology November 1 2001, 28 (11) 2494-2503;

  19. St-Pierre, Y

    1. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
      A E Clarke, Y St-Pierre, L Joseph, J Penrod, J T Sibley, M Haga and H K Genant
      The Journal of Rheumatology November 1 2001, 28 (11) 2416-2424;

  20. Stark, P

    1. Sjögren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis.
      Y Molad, E Okon, P Stark and M Prokocimer
      The Journal of Rheumatology November 1 2001, 28 (11) 2551-2552;

  21. Sternberg, E M

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

  22. Storri, L

    1. Quadricepital tendon enthesitis in psoriatic arthritis and rheumatoid arthritis: ultrasound examinations and clinical correlations.
      B Frediani, P Falsetti, L Storri, A Allegri, S Bisogno, F Baldi and R Marcolongo
      The Journal of Rheumatology November 1 2001, 28 (11) 2566-2568;

  23. Stucki, G

    1. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
      J P Kaltwasser, U Kessler, R Gottschalk, G Stucki and B Möller
      The Journal of Rheumatology November 1 2001, 28 (11) 2430-2436;

  24. Suzuki, J

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

T

  1. Takasaki, Y

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

  2. Takehara, K

    1. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
      S Sato, K Komura, M Hasegawa, M Fujimoto and K Takehara
      The Journal of Rheumatology November 1 2001, 28 (11) 2460-2465;

  3. Teaford, H G

    1. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
      P S Kelkar, J H Butterfield and H G Teaford
      The Journal of Rheumatology November 1 2001, 28 (11) 2553-2554;

  4. Todesco, S

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  5. Toivanen, P

    1. Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis.
      S Nikkari, M Puolakkainen, A Närvänen, O Aakre, P Toivanen and M Leirisalo-Repo
      The Journal of Rheumatology November 1 2001, 28 (11) 2487-2493;

  6. Tokano, Y

    1. Serum levels of interleukin 15 in patients with rheumatic diseases.
      J Suzuki, S Morimoto, H Amano, Y Tokano, Y Takasaki and H Hashimoto
      The Journal of Rheumatology November 1 2001, 28 (11) 2389-2391;

  7. Turner, G

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

U

  1. Ullman, S

    1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
      S Jacobsen, S Ullman, G Q Shen, A Wiik and P Halberg
      The Journal of Rheumatology November 1 2001, 28 (11) 2454-2459;

  2. Umezu, H

    1. Images in rheumatology. Hemorrhagic schwannoma with purely cystic appearance in the shoulder.
      A Ogose, T Hotta, H Koda, H Umezu and T Higuchi
      The Journal of Rheumatology November 1 2001, 28 (11) 2558-2559;

  3. Urowitz, M B

    1. How do I know thee...? Let me count the ways. The varieties of medical evidence.
      M B Urowitz
      The Journal of Rheumatology November 1 2001, 28 (11) 2373-2374;

V

  1. Verdoncq, B

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  2. Verhaar, J

    1. Influence of work on the development of osteoarthritis of the hip: a systematic review.
      A Lievense, S Bierma-Zeinstra, A Verhagen, J Verhaar and B Koes
      The Journal of Rheumatology November 1 2001, 28 (11) 2520-2528;

  3. Verhagen, A

    1. Influence of work on the development of osteoarthritis of the hip: a systematic review.
      A Lievense, S Bierma-Zeinstra, A Verhagen, J Verhaar and B Koes
      The Journal of Rheumatology November 1 2001, 28 (11) 2520-2528;

  4. Vezzù, M

    1. Vascular changes in psoriatic knee joint synovitis.
      U Fiocco, L Cozzi, F Chieco-Bianchi, C Rigon, M Vezzù, E Favero, F Ferro, P Sfriso, L Rubaltelli, R Nardacchione and S Todesco
      The Journal of Rheumatology November 1 2001, 28 (11) 2480-2486;

  5. Vieth, R

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  6. Vreugdenhil, E

    1. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
      R H Derijk, M J Schaaf, G Turner, N A Datson, E Vreugdenhil, J Cidlowski, E R de Kloet, P Emery, E M Sternberg and S D Detera-Wadleigh
      The Journal of Rheumatology November 1 2001, 28 (11) 2383-2388;

W

  1. Walsh, S J

    1. Factors associated with continued employment among patients with rheumatoid arthritis: a survival model.
      S Reisine, J Fifield, S J Walsh and R Feinn
      The Journal of Rheumatology November 1 2001, 28 (11) 2400-2408;

  2. Wechsler, B

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  3. Wells, G A

    1. The effect of low dose methotrexate on bone density.
      A B Cranney, R J McKendry, G A Wells, D S Ooi, N D Kanigsberg, G R Kraag and C D Smith
      The Journal of Rheumatology November 1 2001, 28 (11) 2395-2399;

  4. West, J

    1. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
      P Gordon, J West, H Jones and T Gibson
      The Journal of Rheumatology November 1 2001, 28 (11) 2409-2415;

  5. White, K P

    1. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.
      A M Huisman, K P White, A Algra, M Harth, R Vieth, J W Jacobs, J W Bijlsma and D A Bell
      The Journal of Rheumatology November 1 2001, 28 (11) 2535-2539;

  6. Wigley, R D

    1. Hyaluronic acid serum levels in fibromyalgia, nonspecific arm disorder, and controls.
      R D Wigley, B Page and E M Chambers
      The Journal of Rheumatology November 1 2001, 28 (11) 2563;

  7. Wiik, A

    1. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
      S Jacobsen, S Ullman, G Q Shen, A Wiik and P Halberg
      The Journal of Rheumatology November 1 2001, 28 (11) 2454-2459;

  8. Williams, D

    1. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness.
      F Petzke, A Khine, D Williams, K Groner, D J Clauw and R H Gracely
      The Journal of Rheumatology November 1 2001, 28 (11) 2568-2569;

Z

  1. Zelazko, M

    1. Juvenile rheumatoid arthritis-like polyarthritis in Nijmegen breakage syndrome.
      S D Rosenzweig, R A Russo, M Gallego and M Zelazko
      The Journal of Rheumatology November 1 2001, 28 (11) 2548-2550;

  2. Ziza, J M

    1. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
      P Cacoub, K Chemlal, P Khalifa, B Wechsler, C De Gennes, N Belmatoug, P Cohen, J M Ziza, B Verdoncq and J C Piette
      The Journal of Rheumatology November 1 2001, 28 (11) 2474-2479;

  3. Zummer, M

    1. Living with lupus: a prospective pan-Canadian study.
      P L Dobkin, D Da Costa, P R Fortin, S Edworthy, S Barr, J M Esdaile, J L Senécal, J R Goulet, D Choquette, E Rich, A Beaulieu, A Cividino, S Ensworth, D Smith, M Zummer, D Gladman and A E Clarke
      The Journal of Rheumatology November 1 2001, 28 (11) 2442-2448;
Back to top

In this issue